Assessing Angiogenesis in Breast Cancer
Author Information
Author(s): L Martin, B Green, C Renshaw, D Lowe, P Rudland, SJ Leinster, J Winstanley
Primary Institution: University of Liverpool
Hypothesis
The study aims to determine which monoclonal antibody provides the best visualization of microvessels in invasive breast cancer.
Conclusion
The study found that the highest microvessel density is associated with poorer patient prognosis in invasive breast cancer.
Supporting Evidence
- Anti-CD34 showed the strongest association with patient survival.
- Patients with lower microvessel counts survived longer than those with higher counts.
- The study validated the role of angiogenesis in breast cancer prognosis.
Takeaway
This study looked at how blood vessel growth in breast cancer can help predict how patients will do. They found that more blood vessels usually mean worse outcomes.
Methodology
The study used immunohistochemical staining of microvessels in breast cancer specimens with three different monoclonal antibodies and counted the vessels in ten fields at high magnification.
Limitations
The study's results are based on descriptive statistics and require prospective validation.
Participant Demographics
Patients included had primary, unilateral breast cancer treated by surgery and had no other primary cancer or disseminated disease.
Statistical Information
P-Value
P = 0.0014 for anti-CD34 highest count
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website